FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154940301> ?p ?o ?g. }

• W2154940301 endingPage "849" @default.
• W2154940301 startingPage "849" @default.
• W2154940301 abstract "Clopidogrel therapy improves cardiovascular outcomes in patients with acute coronary syndromes and following percutaneous coronary intervention by inhibiting adenosine diphosphate (ADP)-dependent platelet activation. However, nonresponsiveness is widely recognized and is related to recurrent ischemic events.To identify gene variants that influence clopidogrel response.In the Pharmacogenomics of Antiplatelet Intervention (PAPI) Study (2006-2008), we administered clopidogrel for 7 days to 429 healthy Amish persons and measured response by ex vivo platelet aggregometry. A genome-wide association study was performed followed by genotyping the loss-of-function cytochrome P450 (CYP) 2C19*2 variant (rs4244285). Findings in the PAPI Study were extended by examining the relation of CYP2C19*2 genotype to platelet function and cardiovascular outcomes in an independent sample of 227 patients undergoing percutaneous coronary intervention.ADP-stimulated platelet aggregation in response to clopidogrel treatment and cardiovascular events.Platelet response to clopidogrel was highly heritable (h(2) = 0.73; P < .001). Thirteen single-nucleotide polymorphisms on chromosome 10q24 within the CYP2C18-CYP2C19-CYP2C9-CYP2C8 cluster were associated with diminished clopidogrel response, with a high degree of statistical significance (P = 1.5 x 10(-13) for rs12777823, additive model). The rs12777823 polymorphism was in strong linkage disequilibrium with the CYP2C19*2 variant, and was associated with diminished clopidogrel response, accounting for 12% of the variation in platelet aggregation to ADP (P = 4.3 x 10(-11)). The relation between CYP2C19*2 genotype and platelet aggregation was replicated in clopidogrel-treated patients undergoing coronary intervention (P = .02). Furthermore, patients with the CYP2C19*2 variant were more likely (20.9% vs 10.0%) to have a cardiovascular ischemic event or death during 1 year of follow-up (hazard ratio, 2.42; 95% confidence interval, 1.18-4.99; P = .02).CYP2C19*2 genotype was associated with diminished platelet response to clopidogrel treatment and poorer cardiovascular outcomes." @default.
• W2154940301 created "2016-06-24" @default.
• W2154940301 creator A5007408007 @default.
• W2154940301 creator A5011626347 @default.
• W2154940301 creator A5012918602 @default.
• W2154940301 creator A5017178370 @default.
• W2154940301 creator A5021669286 @default.
• W2154940301 creator A5024158146 @default.
• W2154940301 creator A5027947946 @default.
• W2154940301 creator A5032058628 @default.
• W2154940301 creator A5035654131 @default.
• W2154940301 creator A5039130551 @default.
• W2154940301 creator A5043833054 @default.
• W2154940301 creator A5047340885 @default.
• W2154940301 creator A5050840454 @default.
• W2154940301 creator A5055505910 @default.
• W2154940301 creator A5057382086 @default.
• W2154940301 creator A5087289434 @default.
• W2154940301 creator A5091662393 @default.
• W2154940301 date "2009-08-26" @default.
• W2154940301 modified "2023-10-13" @default.
• W2154940301 title "Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy" @default.
• W2154940301 cites W1608256683 @default.
• W2154940301 cites W168371622 @default.
• W2154940301 cites W1726466368 @default.
• W2154940301 cites W178249453 @default.
• W2154940301 cites W1898846685 @default.
• W2154940301 cites W1952796400 @default.
• W2154940301 cites W1966493516 @default.
• W2154940301 cites W1975793175 @default.
• W2154940301 cites W1985059672 @default.
• W2154940301 cites W1985835171 @default.
• W2154940301 cites W1993051841 @default.
• W2154940301 cites W1995077251 @default.
• W2154940301 cites W2001141842 @default.
• W2154940301 cites W2007108997 @default.
• W2154940301 cites W2010080412 @default.
• W2154940301 cites W2012268722 @default.
• W2154940301 cites W2021241943 @default.
• W2154940301 cites W2021341882 @default.
• W2154940301 cites W2026270873 @default.
• W2154940301 cites W2044901769 @default.
• W2154940301 cites W2046551905 @default.
• W2154940301 cites W2047376380 @default.
• W2154940301 cites W2050821039 @default.
• W2154940301 cites W2056296054 @default.
• W2154940301 cites W2060063218 @default.
• W2154940301 cites W2089826028 @default.
• W2154940301 cites W2102296549 @default.
• W2154940301 cites W2104595603 @default.
• W2154940301 cites W2107001549 @default.
• W2154940301 cites W2110897264 @default.
• W2154940301 cites W2115335486 @default.
• W2154940301 cites W2120603250 @default.
• W2154940301 cites W2135575592 @default.
• W2154940301 cites W2143777566 @default.
• W2154940301 cites W2144183240 @default.
• W2154940301 cites W2147746835 @default.
• W2154940301 cites W2148633205 @default.
• W2154940301 cites W2159670968 @default.
• W2154940301 cites W2159858918 @default.
• W2154940301 cites W2162245427 @default.
• W2154940301 cites W2170125927 @default.
• W2154940301 cites W2616526627 @default.
• W2154940301 cites W2339793680 @default.
• W2154940301 doi "https://doi.org/10.1001/jama.2009.1232" @default.
• W2154940301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3641569" @default.
• W2154940301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19706858" @default.
• W2154940301 hasPublicationYear "2009" @default.
• W2154940301 type Work @default.
• W2154940301 sameAs 2154940301 @default.
• W2154940301 citedByCount "1349" @default.
• W2154940301 countsByYear W21549403012012 @default.
• W2154940301 countsByYear W21549403012013 @default.
• W2154940301 countsByYear W21549403012014 @default.
• W2154940301 countsByYear W21549403012015 @default.
• W2154940301 countsByYear W21549403012016 @default.
• W2154940301 countsByYear W21549403012017 @default.
• W2154940301 countsByYear W21549403012018 @default.
• W2154940301 countsByYear W21549403012019 @default.
• W2154940301 countsByYear W21549403012020 @default.
• W2154940301 countsByYear W21549403012021 @default.
• W2154940301 countsByYear W21549403012022 @default.
• W2154940301 countsByYear W21549403012023 @default.
• W2154940301 crossrefType "journal-article" @default.
• W2154940301 hasAuthorship W2154940301A5007408007 @default.
• W2154940301 hasAuthorship W2154940301A5011626347 @default.
• W2154940301 hasAuthorship W2154940301A5012918602 @default.
• W2154940301 hasAuthorship W2154940301A5017178370 @default.
• W2154940301 hasAuthorship W2154940301A5021669286 @default.
• W2154940301 hasAuthorship W2154940301A5024158146 @default.
• W2154940301 hasAuthorship W2154940301A5027947946 @default.
• W2154940301 hasAuthorship W2154940301A5032058628 @default.
• W2154940301 hasAuthorship W2154940301A5035654131 @default.
• W2154940301 hasAuthorship W2154940301A5039130551 @default.
• W2154940301 hasAuthorship W2154940301A5043833054 @default.
• W2154940301 hasAuthorship W2154940301A5047340885 @default.
• W2154940301 hasAuthorship W2154940301A5050840454 @default.

• next